The pharmacokinetic evaluation and pharmacodynamics of the Asp-insulin by oral administration with those of the subcutaneous injection of NPH-insulin (or isophane insulin) that is an intermediate–acting insulin given to assist blood sugar level controlling in people with diabetes suggested the significance of this NP system to be used as a non-invasive alternative for the basal insulin therapy. Here, INS is linked to diabetes mellitus.